Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Safety and Immunogenicity of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by VABIOTECH (Vietnam) in Vietnamese Children Aged 9-24 Months

NCT03282370 is registered in ClinicalTrials.gov with National Institute of Hygiene and Epidemiology, Vietnam as lead sponsor.

NCT NCT03282370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03282370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Safety and Immunogenicity of a Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) Produced by VABIOTECH (Vietnam) in Vietnamese Children Aged 9-24 Months
Lead sponsor
National Institute of Hygiene and Epidemiology, Vietnam
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2017
Completion date
April 8, 2018
Enrollment
655 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

japanese encephalitis